{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:08:10Z","timestamp":1794049690412,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 MH084894"],"award-info":[{"award-number":["R01 MH084894"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01MH111940"],"award-info":[{"award-number":["R01MH111940"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Spanish Ministry of Science, Innovation and Universities","award":["SAF2009-08460"],"award-info":[{"award-number":["SAF2009-08460"]}]},{"name":"Spanish Ministry of Science, Innovation and Universities","award":["2017-88126-R"],"award-info":[{"award-number":["2017-88126-R"]}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"crossref","award":["IT-616-13"],"award-info":[{"award-number":["IT-616-13"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"crossref","award":["IT-1211-19"],"award-info":[{"award-number":["IT-1211-19"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.euroneuro.2019.10.013","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T02:56:38Z","timestamp":1573700198000},"page":"1453-1463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via G\u03b1i1-proteins"],"prefix":"10.1016","volume":"29","author":[{"given":"Aintzane","family":"Garc\u00eda-Bea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Miranda-Azpiazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Muguruza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Marmolejo-Martinez-Artesero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0806-9825","authenticated-orcid":false,"given":"Rebeca","family":"Diez-Alarcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1892-3861","authenticated-orcid":false,"given":"Ane M","family":"Gabilondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9941-012X","authenticated-orcid":false,"given":"Luis F","family":"Callado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3396-3527","authenticated-orcid":false,"given":"Benito","family":"Morentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gonz\u00e1lez-Maeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Javier","family":"Meana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2019.10.013_bib0001","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.schres.2011.04.007","article-title":"Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder","volume":"129","author":"Abdolmaleky","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1192\/bjp.108.452.95","article-title":"Effects of LSD-25 on relatives of schizophrenic patients","volume":"108","author":"Anastasopoulos","year":"1962","journal-title":"J. Ment. Sci."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0003","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1074\/jbc.M006968200","article-title":"The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis","volume":"276","author":"Bhatnagar","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0004","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0893-133X(96)00053-X","article-title":"5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia","volume":"15","author":"Burnet","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0005","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1017\/S0033291715002901","article-title":"The paradoxical psychological effects of lysergic acid diethylamide (LSD)","volume":"46","author":"Carhart-Harris","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0006","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.biopsych.2008.03.013","article-title":"The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs","volume":"64","author":"Celada","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/genes8010014","article-title":"mRNA expression and DNA methylation analysis of serotonin receptor 2A (HTR2A) in the human schizophrenic brain","volume":"8","author":"Cheah","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2003.01693.x","article-title":"The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice","volume":"85","author":"Dean","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0009","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.schres.2008.06.011","article-title":"Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia","volume":"104","author":"Dean","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.schres.2007.10.013","article-title":"Increased levels of serotonin2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic\/mutant mice","volume":"99","author":"Dean","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0011","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fphar.2016.00415","article-title":"Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex","volume":"7","author":"Diez-Alarcia","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0012","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/syn.1106","article-title":"Expression of serotonin 5-HT2A receptors in the human cerebellum and alterations in schizophrenia","volume":"42","author":"Eastwood","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0013","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bcp.2011.10.018","article-title":"The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain","volume":"83","author":"Erdozain","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0014","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/sj.npp.1301656","article-title":"Cortical and subcortical 5-HT2A receptor binding in neuroleptic-na\u00efve first-episode schizophrenic patients","volume":"33","author":"Erritzoe","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0015","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s12035-017-0457-y","article-title":"Differences in 5-HT2A and mGlu2 receptor expression levels and repressive epigenetic modifications at the 5-HT2A promoter region in the Roman Low- (RLA-I) and High- (RHA-I) Avoidance rat strains","volume":"55","author":"Fomsgaard","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0016","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","article-title":"Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs","volume":"147","author":"Fribourg","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0017","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuroscience.2008.09.002","article-title":"Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers","volume":"157","author":"Garc\u00eda-Fuster","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0018","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","article-title":"Serotonin research: contributions to understanding psychoses","volume":"29","author":"Geyer","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonz\u00e1lez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2008.12.005","article-title":"Psychedelics and schizophrenia","volume":"32","author":"Gonz\u00e1lez-Maeso","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0021","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0022","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1523\/JNEUROSCI.23-26-08836.2003","article-title":"Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex","volume":"23","author":"Gonz\u00e1lez-Maeso","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0023","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1017\/S1461145713000722","article-title":"Serotonergic hallucinogens as translational models relevant to schizophrenia","volume":"16","author":"Halberstadt","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0024","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/(SICI)1097-4547(20000115)59:2<218::AID-JNR8>3.0.CO;2-H","article-title":"Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment","volume":"59","author":"Hernandez","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1176\/ajp.108.8.579","article-title":"Effects of mescaline and lysergic acid (d-LSD-25)","volume":"108","author":"Hoch","year":"1952","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0026","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1523\/JNEUROSCI.2331-12.2013","article-title":"Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system","volume":"33","author":"Holloway","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0027","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/s41386-018-0076-y","article-title":"Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt\/mTOR pathway","volume":"43","author":"Ibarra-Lecue","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.med.58.060904.084114","article-title":"Schizophrenia: new pathological insights and therapies","volume":"58","author":"Jarskog","year":"2007","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0029","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1074\/mcp.M113.036558","article-title":"Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists","volume":"13","author":"Karaki","year":"2014","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00210-004-0951-4","article-title":"Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors","volume":"370","author":"Knight","year":"2004","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0031","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nn.3181","article-title":"HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity","volume":"15","author":"Kurita","year":"2012","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0032","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1021\/acschemneuro.8b00176","article-title":"Classics in neuroimaging: the serotonergic 2A receptor system \u2013 from discovery to modern molecular imaging","volume":"9","author":"L'Estrade","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0033","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.npp.1301563","article-title":"Neuroplasticity of neocortical circuits in schizophrenia","volume":"33","author":"Lewis","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0034","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.biopsych.2003.09.017","article-title":"Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia","volume":"55","author":"L\u00f3pez-Figueroa","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0035","doi-asserted-by":"crossref","first-page":"E2492","DOI":"10.1073\/pnas.1323287111","article-title":"Manganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia","volume":"111","author":"Malkova","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0036","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.euroneuro.2019.10.013_bib0037","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1016\/S0924-977X(13)70309-2","article-title":"Hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists induce distinct patterns of G protein activation of G protein coupling in postmortem human brain","volume":"23","author":"Miranda-Azpiazu","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0038","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0039","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00213-012-2809-7","article-title":"Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice","volume":"225","author":"Moreno","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0040","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1523\/JNEUROSCI.4230-10.2011","article-title":"Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT2A and mGlu2 receptors in the adult offspring","volume":"31","author":"Moreno","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0041","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuropharm.2014.08.009","article-title":"Evaluation of 5-HT2A and mGlu2\/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment","volume":"86","author":"Muguruza","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0042","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.euroneuro.2012.10.006","article-title":"Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects","volume":"23","author":"Muguruza","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0043","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0044","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1523\/JNEUROSCI.1939-17.2018","article-title":"Role of the 5-HT2A receptor in self- and other-initiated social interaction in lysergic acid diethylamide-induced states: a pharmacological fMRI study","volume":"38","author":"Preller","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0045","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/npp.2011.228","article-title":"Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers","volume":"37","author":"Quednow","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0046","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/cercor\/5.4.323","article-title":"Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System","volume":"5","author":"Rajkowska","year":"1995","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0047","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archgenpsychiatry.2009.176","article-title":"Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia","volume":"67","author":"Rasmussen","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0048","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.euroneuro.2016.04.008","article-title":"Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?","volume":"26","author":"Rasmussen","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0049","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neuropharm.2011.01.012","article-title":"Irving Page Lecture: 5-HT2A serotonin receptor biology: interacting proteins, kinases and paradoxical regulation","volume":"61","author":"Roth","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0050","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jnr.23198","article-title":"Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia","volume":"91","author":"Santini","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0051","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0052","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neubiorev.2014.06.005","article-title":"Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies","volume":"45","author":"Selvaraj","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.09.025","article-title":"Human postmortem tissue: what quality markers matter?","volume":"1123","author":"Stan","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0054","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41398-018-0309-1","article-title":"Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity","volume":"8","author":"Underwood","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0056","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/jpet.111.183780","article-title":"Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo","volume":"339","author":"Yadav","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2019.10.013_bib0057","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpsychires.2015.06.010","article-title":"Different stress-related gene expression in depression and suicide","volume":"68","author":"Zhao","year":"2015","journal-title":"J. Psychiatr. Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19317250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19317250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:55:05Z","timestamp":1760378105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X19317250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0924977X19317250"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.10.013","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via G\u03b1i1-proteins","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}